EA201100626A1 - Лечение рака с помощью ионизирующего облучения и иммуноцитокинов - Google Patents
Лечение рака с помощью ионизирующего облучения и иммуноцитокиновInfo
- Publication number
- EA201100626A1 EA201100626A1 EA201100626A EA201100626A EA201100626A1 EA 201100626 A1 EA201100626 A1 EA 201100626A1 EA 201100626 A EA201100626 A EA 201100626A EA 201100626 A EA201100626 A EA 201100626A EA 201100626 A1 EA201100626 A1 EA 201100626A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- immunocytokins
- cancer
- help
- treatment
- ionizing radiation
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 201000011510 cancer Diseases 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000005865 ionizing radiation Effects 0.000 title 1
- 229940127130 immunocytokine Drugs 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 1
- 231100000682 maximum tolerated dose Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10714608P | 2008-10-21 | 2008-10-21 | |
| PCT/EP2009/007533 WO2010046097A1 (en) | 2008-10-21 | 2009-10-21 | Cancer treatments with radiation and immunocytokines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201100626A1 true EA201100626A1 (ru) | 2011-12-30 |
Family
ID=41510762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201100626A EA201100626A1 (ru) | 2008-10-21 | 2009-10-21 | Лечение рака с помощью ионизирующего облучения и иммуноцитокинов |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100330029A1 (https=) |
| EP (1) | EP2337579A1 (https=) |
| JP (1) | JP2012506394A (https=) |
| KR (1) | KR20110086101A (https=) |
| CN (1) | CN102196815A (https=) |
| AU (1) | AU2009306711A1 (https=) |
| BR (1) | BRPI0919857A2 (https=) |
| CA (1) | CA2741130A1 (https=) |
| EA (1) | EA201100626A1 (https=) |
| MX (1) | MX2011004193A (https=) |
| WO (1) | WO2010046097A1 (https=) |
| ZA (1) | ZA201103726B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3107573T (pt) * | 2014-02-19 | 2019-01-10 | Merck Patent Gmbh | Imunoterapia com il-12 visada ao cancro |
| BR112019018915A2 (pt) | 2017-03-15 | 2020-04-14 | Pandion Therapeutics Inc | imunotolerância direcionada |
| US9861833B1 (en) * | 2017-03-30 | 2018-01-09 | Norman H. Anderson | Methods of treating melanoma |
| JP2020521452A (ja) | 2017-05-24 | 2020-07-27 | パンディオン・セラピューティクス・インコーポレイテッド | 標的化免疫寛容 |
| US10174091B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
| US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| USRE50550E1 (en) | 2017-12-06 | 2025-08-26 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| WO2020236875A1 (en) | 2019-05-20 | 2020-11-26 | Pandion Therapeutics, Inc. | Madcam targeted immunotolerance |
| US11981715B2 (en) | 2020-02-21 | 2024-05-14 | Pandion Operations, Inc. | Tissue targeted immunotolerance with a CD39 effector |
| CN112768029B (zh) * | 2020-12-27 | 2023-10-13 | 上海市东方医院（同济大学附属东方医院） | 一种基于单细胞测序的组合用药推荐设备、方法及介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2457701A (en) * | 1999-12-28 | 2001-07-09 | Brown University Research Foundation | Methods and products for tumor immunotherapy using cytokines |
| DE60129695T2 (de) * | 2000-06-29 | 2008-06-05 | Merck Patent Gmbh | Steigerung von durch antikörper-zytokin-fusionsproteine mediierten immunantworten durch eine kombinierte behandlung mit mitteln zur erhöhung der immunzytokinaufnahme |
| PT1454138E (pt) * | 2001-12-04 | 2012-03-28 | Merck Patent Gmbh | Imunocitoquinas com seletividade modulada |
| CA2593648A1 (en) * | 2005-01-10 | 2006-07-13 | Research Development Foundation | Targeted chimeric molecules for cancer therapy |
| BRPI0620648B1 (pt) * | 2005-12-30 | 2022-12-20 | Merck Patent Gesellschaft Mit Beschrãnkter Haftung | Variante de il-12 p40, proteínas il-12, il-23 e de fusão, composição farmacêutica e uso da mesma |
-
2009
- 2009-10-21 JP JP2011532532A patent/JP2012506394A/ja active Pending
- 2009-10-21 BR BRPI0919857A patent/BRPI0919857A2/pt not_active IP Right Cessation
- 2009-10-21 MX MX2011004193A patent/MX2011004193A/es not_active Application Discontinuation
- 2009-10-21 KR KR1020117011503A patent/KR20110086101A/ko not_active Ceased
- 2009-10-21 WO PCT/EP2009/007533 patent/WO2010046097A1/en not_active Ceased
- 2009-10-21 CA CA2741130A patent/CA2741130A1/en not_active Abandoned
- 2009-10-21 EP EP09740858A patent/EP2337579A1/en not_active Withdrawn
- 2009-10-21 CN CN2009801417993A patent/CN102196815A/zh active Pending
- 2009-10-21 US US12/603,363 patent/US20100330029A1/en not_active Abandoned
- 2009-10-21 EA EA201100626A patent/EA201100626A1/ru unknown
- 2009-10-21 AU AU2009306711A patent/AU2009306711A1/en not_active Abandoned
-
2011
- 2011-05-20 ZA ZA2011/03726A patent/ZA201103726B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010046097A1 (en) | 2010-04-29 |
| MX2011004193A (es) | 2011-05-24 |
| JP2012506394A (ja) | 2012-03-15 |
| BRPI0919857A2 (pt) | 2015-12-15 |
| CN102196815A (zh) | 2011-09-21 |
| ZA201103726B (en) | 2012-01-25 |
| US20100330029A1 (en) | 2010-12-30 |
| CA2741130A1 (en) | 2010-04-29 |
| EP2337579A1 (en) | 2011-06-29 |
| AU2009306711A1 (en) | 2010-04-29 |
| KR20110086101A (ko) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201100626A1 (ru) | Лечение рака с помощью ионизирующего облучения и иммуноцитокинов | |
| CY1123258T1 (el) | Μεθοδος θεραπειας για τον καρκινο | |
| EA200970915A1 (ru) | Способы лечения с использованием гликопэгилированного g-csf | |
| MX2020009773A (es) | Terapia de combinacion. | |
| SG10201902664RA (en) | Combination therapy for treating cancer | |
| CY1115782T1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| MXPA05011656A (es) | Combinaciones para el tratamiento de enfermedades que implican proliferacion, migracion o apoptosis celulares de celulas de mieloma, o angiogenesis. | |
| WO2011146777A3 (en) | Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain | |
| PH12015502260B1 (en) | C. novyi for the treatment of solid tumors in humans | |
| MX2020001727A (es) | Terapia de combinacion. | |
| UA86586C2 (ru) | Комбинация для лечения заболеваний, связанных с клеточной пролиферацией, миграцией или апоптозом клеток миеломы или с ангиогенезом | |
| MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
| EA201001853A1 (ru) | Фармацевтическая комбинация | |
| PH12021551276A1 (en) | Combination therapy for the treatment of cancer | |
| MX2025008270A (es) | Uso prolongado de docetaxel en el tratamiento del cáncer. | |
| EA202192964A1 (ru) | Комбинированная терапия | |
| MX2021001764A (es) | Terapia de combinacion. | |
| MX393477B (es) | Combinación de vorasidenib con radiación y/o agentes adicionales para tratar gliomas. | |
| NZ760040A (en) | Methods of treating brain tumors using combination therapy | |
| BR112022001796A2 (pt) | Tratamento focal do câncer de próstata | |
| MX2024006078A (es) | Metodo para tratar el cancer con acilfulveno y radiacion. | |
| ATE442188T1 (de) | Bestrahlungseinrichtung | |
| TW200724158A (en) | Combination therapy in the treatment of cancer | |
| EA202190294A1 (ru) | Комбинированная терапия для лечения рака | |
| MX2017013668A (es) | Terapia de combinacion de agente anti-fuctactico y agente anti-cancer y composiciones para el tratamiento de cancer. |